ATE132857T1 - Lipoxygenase inhibierende tetrahydrobenzazepinderivate - Google Patents

Lipoxygenase inhibierende tetrahydrobenzazepinderivate

Info

Publication number
ATE132857T1
ATE132857T1 AT92911321T AT92911321T ATE132857T1 AT E132857 T1 ATE132857 T1 AT E132857T1 AT 92911321 T AT92911321 T AT 92911321T AT 92911321 T AT92911321 T AT 92911321T AT E132857 T1 ATE132857 T1 AT E132857T1
Authority
AT
Austria
Prior art keywords
alkyl
pct
lipoxygenase
sec
arylalkyl
Prior art date
Application number
AT92911321T
Other languages
English (en)
Inventor
Takafumi Ikeda
Yoko Hoshino
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE132857T1 publication Critical patent/ATE132857T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
AT92911321T 1991-06-28 1992-05-27 Lipoxygenase inhibierende tetrahydrobenzazepinderivate ATE132857T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3158832A JPH0717612B2 (ja) 1991-06-28 1991-06-28 新規なテトラヒドロベンズアゼピン誘導体

Publications (1)

Publication Number Publication Date
ATE132857T1 true ATE132857T1 (de) 1996-01-15

Family

ID=15680372

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92911321T ATE132857T1 (de) 1991-06-28 1992-05-27 Lipoxygenase inhibierende tetrahydrobenzazepinderivate

Country Status (13)

Country Link
US (1) US5478822A (de)
EP (1) EP0591255B1 (de)
JP (1) JPH0717612B2 (de)
AT (1) ATE132857T1 (de)
CA (1) CA2111460C (de)
DE (1) DE69207597T2 (de)
DK (1) DK0591255T3 (de)
ES (1) ES2082474T3 (de)
FI (1) FI935867A0 (de)
GR (1) GR3019196T3 (de)
IE (1) IE70234B1 (de)
PT (1) PT100628A (de)
WO (1) WO1993000335A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0710233B1 (de) * 1993-07-20 1999-10-13 Pfizer Inc. Heteroaryl-cyloalkenyl-hydroxy-harnstoeffe
JP2001501172A (ja) * 1996-08-15 2001-01-30 スミスクライン・ビーチャム・コーポレイション Il―8レセプターアンタゴニスト
EP1056187A4 (de) 1998-02-13 2005-11-02 Yaskawa Denki Seisakusho Kk Linearmotor
US7229986B2 (en) 2000-05-16 2007-06-12 Takeda Pharmaceutical Company Ltd. Melanin-concentrating hormone antagonist

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT82200B (pt) * 1985-03-16 1990-02-08 Wellcome Found Processo para a preparacao de novos derivados do acido hidroxamico e de composicoes farmaceuticas que os contem
ES2059408T3 (es) * 1987-02-10 1994-11-16 Abbott Lab Un proceso para la preparacion de un compuesto.
EP0292699B1 (de) * 1987-04-24 1994-03-23 Abbott Laboratories Harnstoff-Derivate mit lipoxygenasehemmender Wirkung
US4981865A (en) * 1989-05-26 1991-01-01 Warner-Lambert Co. N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents

Also Published As

Publication number Publication date
PT100628A (pt) 1993-09-30
FI935867L (fi) 1993-12-27
FI935867A7 (fi) 1993-12-27
DE69207597T2 (de) 1996-05-23
DE69207597D1 (de) 1996-02-22
JPH059181A (ja) 1993-01-19
EP0591255A1 (de) 1994-04-13
ES2082474T3 (es) 1996-03-16
EP0591255B1 (de) 1996-01-10
IE70234B1 (en) 1996-11-13
US5478822A (en) 1995-12-26
WO1993000335A1 (en) 1993-01-07
JPH0717612B2 (ja) 1995-03-01
FI935867A0 (fi) 1993-12-27
CA2111460C (en) 1996-11-19
CA2111460A1 (en) 1993-01-07
DK0591255T3 (da) 1996-02-12
GR3019196T3 (en) 1996-06-30
IE922075A1 (en) 1992-12-30

Similar Documents

Publication Publication Date Title
DK0620216T3 (da) Benzamidderivater og deres anvendelse som vasopressinantagonister
DK0794949T3 (da) Hidtil ukendte 3,5-dioxo-(2H,4H)-1,2,4-triazinderivater, fremstilling heraf og deres anvendelse som lægemidler
YU34896A (sh) Supstituisani n-(indol-2-karbonil)-glicinamidi, njihovi intermedijeri i farmaceutske kompozicije
YU48089B (sh) Novi derivati tetrazola i postupak za njihovo pripremanje
PT1044186E (pt) Composto 2-benzilamino-2-fenil-acetamida substituidos
ATE224372T1 (de) Substituierte 6-alkylphenanthridine
NZ334701A (en) Dihydropyrones and use in treating retrovirus infections and diseases
MX9400253A (es) Derivados de piperazina, proceso para su preparacion y composiciones farmaceuticas que los contienen.
HUT59124A (en) Process for producing 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxane derivatives and pharmaceutical compositions comprising such derivatives as active ingredient
DE69207597D1 (de) Lipoxygenase inhibierende tetrahydrobenzazepinderivate
DK0720598T3 (da) Phenoxyphenylcyclopentenyl-hydroxyurinstoffer
BG106152A (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
DK0588850T3 (da) N-hydroxyureaderivater, som inhiberer lipoxygenase
DK0596917T3 (da) Benzimidazolanthelmintika
KR950702533A (ko) 리폭시게나제 억제제로서의 인돌리닐 n-하이드록시우레아 및 n-하이드록삼산 유도체(indolinyl n-hydroxyurea and n-hydroxamic acid derivatives as lipoxygenase inhibitors)
FI942768A0 (fi) Syklopropyyli-N-hydroksiurea ja N-hydroksiasetamidit, jotka inhiboivat lipoksygenaasia
KR960034199A (ko) 피라졸을 함유한 벤즈이미다졸 유도체

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee